Ahn HK - Search Results

1

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.

Park YH, Kim TY, Kim GM, Kang SY, Park IH, Kim JH, Lee KE, Ahn HK, Lee MH, Kim HJ, Kim HJ, Lee JI, Koh SJ, Kim JY, Lee KH, Sohn J, Kim SB, Ahn JS, Im YH, Jung KH, Im SA; Korean Cancer Study Group (KCSG). Park YH, et al. Among authors: ahn js, ahn hk. Lancet Oncol. 2019 Dec;20(12):1750-1759. doi: 10.1016/S1470-2045(19)30565-0. Epub 2019 Oct 24. Lancet Oncol. 2019. PMID: 31668850 Clinical Trial.

2

Clinical presentation of carcinoma of unknown primary: 14 years of experience.

Yi JH, La Choi Y, Lee SJ, Ahn HK, Baek KK, Lim T, Lee DJ, Han BR, Lee HY, Jun HJ, Lee J, Park YH. Yi JH, et al. Among authors: ahn hk. Tumour Biol. 2011 Feb;32(1):45-51. doi: 10.1007/s13277-010-0089-6. Epub 2010 Aug 10. Tumour Biol. 2011. PMID: 20697986

3

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors.

Chang MH, Ahn HK, Lee J, Jung CK, Choi YL, Park YH, Ahn JS, Park K, Ahn MJ. Chang MH, et al. Among authors: ahn js, ahn mj, ahn hk. Cancer. 2011 Jan 1;117(1):143-51. doi: 10.1002/cncr.25560. Epub 2010 Aug 27. Cancer. 2011. PMID: 20803614 Free article.

4

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer.

Lim T, Lee J, Lee DJ, Lee HY, Han B, Baek KK, Ahn HK, Lee SJ, Park SH, Park JO, Park YS, Lim HY, Kim KM, Kang WK. Lim T, et al. Among authors: ahn hk. Cancer Chemother Pharmacol. 2011 Jul;68(1):255-62. doi: 10.1007/s00280-011-1653-5. Epub 2011 Apr 28. Cancer Chemother Pharmacol. 2011. PMID: 21526353 Free PMC article. Clinical Trial.

5

Analysis of prognostic factors of pediatric-type sarcomas in adult patients.

Ahn HK, Uhm JE, Lee J, Lim DH, Seo SW, Sung KS, Lee SJ, Lee DJ, Baek KK, Kim WS, Park JO. Ahn HK, et al. Oncology. 2011;80(1-2):21-8. doi: 10.1159/000327222. Epub 2011 May 23. Oncology. 2011. PMID: 21606660

6

Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations.

Lee S, Ahn HK, Park YH, Nam DH, Lee JI, Park W, Choi DH, Huh SJ, Park KT, Ahn JS, Im YH. Lee S, et al. Among authors: ahn js, ahn hk. Breast Cancer Res Treat. 2011 Oct;129(3):809-17. doi: 10.1007/s10549-011-1682-0. Epub 2011 Jul 23. Breast Cancer Res Treat. 2011. PMID: 21785952 Clinical Trial.

7

Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer.

Lee SJ, Park S, Ahn HK, Yi JH, Cho EY, Sun JM, Lee JE, Nam SJ, Yang JH, Park YH, Ahn JS, Im YH. Lee SJ, et al. Among authors: ahn js, ahn hk. Cancer Res Treat. 2011 Jun;43(2):89-95. doi: 10.4143/crt.2011.43.2.89. Epub 2011 Jun 30. Cancer Res Treat. 2011. PMID: 21811424 Free PMC article.

8

Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancer.

Park S, Ahn HK, Park LC, Hwang DW, Ji JH, Maeng CH, Cho SH, Lee JY, Park KT, Ahn JS, Park YH, Im YH. Park S, et al. Among authors: ahn js, ahn hk. Oncology. 2012;82(3):180-7. doi: 10.1159/000336081. Epub 2012 Mar 16. Oncology. 2012. PMID: 22433564

9

Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.

Ahn HK, Lee S, Park YH, Sohn JH, Jo JC, Ahn JH, Jung KH, Park S, Cho EY, Lee JI, Park W, Choi DH, Huh SJ, Ahn JS, Kim SB, Im YH. Ahn HK, et al. Among authors: ahn js, ahn jh. Neuro Oncol. 2012 Aug;14(8):1105-13. doi: 10.1093/neuonc/nos137. Epub 2012 Jun 11. Neuro Oncol. 2012. PMID: 22693244 Free PMC article.

10

A case report of paraneoplastic pemphigus associated with esophageal squamous cell carcinoma.

Cho JH, Kim NJ, Ko SM, Kim C, Ahn HK, Yun J, Park YH. Cho JH, et al. Among authors: ahn hk. Cancer Res Treat. 2013 Mar;45(1):70-3. doi: 10.4143/crt.2013.45.1.70. Epub 2013 Mar 31. Cancer Res Treat. 2013. PMID: 23613673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters